MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
255.72%
Quick Ratio
177.66%
Cash Ratio
48.01%
Debt to Asset Ratio
94.02%
Unit: Thousand (K) dollars
Assets Breakdown
Accounts receivable, net
Cash and cash equivalents
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Non-current notes payable, net
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
43,068
16,516
Short-term investments
12,419
24,117
Accounts receivable, net
81,047
79,931
Inventory, net
70,025
72,965
Prepaid expenses and other current assets
22,841
17,394
Total current assets
229,400
210,923
Property and equipment, net
12,960
13,683
Right-of-use lease assets
708
1,401
Other assets
5,882
6,083
Total assets
248,950
232,090
Convertible notes payable, net
-
149,806
Accounts payable
12,017
12,037
Notes payable, net
-
25,398
Accrued clinical and manufacturing liabilities
19,663
17,135
Accrued payroll and employee liabilities
8,748
6,471
Other accrued liabilities
48,500
46,215
Current lease liabilities
780
1,539
Total current liabilities
89,708
258,601
Non-current notes payable, net
107,487
-
Non-current convertible notes payable, net
32,176
-
Other non-current liabilities
4,694
747
Total liabilities
234,065
259,348
Common stock
1,833
1,533
Series a convertible preferred stock
7,862
-
Additional paid-in capital
1,942,025
1,890,550
Accumulated other comprehensive loss
0
-1
Accumulated deficit
-1,936,835
-1,919,340
Total stockholders' equity (deficit)
14,885
-27,258
Total liabilities and stockholders' equity (deficit)
248,950
232,090
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable, net
$81,047K
Inventory, net
$70,025K
Cash and cash
equivalents
$43,068K
Prepaid expenses and
other current assets
$22,841K
Short-term investments
$12,419K
Total current assets
$229,400K
Property and equipment,
net
$12,960K
Other assets
$5,882K
Right-of-use lease assets
$708K
Total assets
$248,950K
Total liabilities and
stockholders' equity...
$248,950K
Total liabilities
$234,065K
Total stockholders'
equity (deficit)
$14,885K
Accumulated deficit
-$1,936,835K
Non-current notes payable,
net
$107,487K
Total current
liabilities
$89,708K
Non-current convertible
notes payable, net
$32,176K
Other non-current
liabilities
$4,694K
Additional paid-in capital
$1,942,025K
Series a convertible
preferred stock
$7,862K
Common stock
$1,833K
Other accrued
liabilities
$48,500K
Accrued clinical and
manufacturing liabilities
$19,663K
Accounts payable
$12,017K
Accrued payroll and
employee liabilities
$8,748K
Current lease
liabilities
$780K
Buy us a coffee
HERON THERAPEUTICS, INC. DE (HRTX)
HERON THERAPEUTICS, INC. DE (HRTX)